Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
algorithm
ANA
angioneurotic edema
angiotensin-converting enzyme
angiotensin-converting enzyme, inhibitors
ankle, swelling of
anticoagulant, treatment
anticoagulant, treatment in CVD
antihypertensive
arachnoiditis
arthritis
atrial fibrillation
bacterial infection
blacks
blood pressure
blood pressure after stroke
blood pressure, control
carotid artery atherosclerosis
carotid artery atherosclerosis, pathogenesis
carotid artery plaque
cauda equina, lesion of
cerebral ischemia
cerebrospinal fluid, abnormal
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, cost of
cerebrovascular accident, pathophysiology
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular disease, risk factors in
cognition
collagen vascular disease
complications
congenital malformation
controversies in neurology
cost effectiveness
cranial neuropathy
delay in diagnosis
diabetes insipidus
differential diagnosis
diuretic
endarterectomy, carotid
epidemiology of neurology
face, numbness of
facial nerve palsy
facial nerve palsy, bilateral
fibrinolytic agents
fibrinolytic agents, complications
gadolinium
gallium scan
granulomatous disease
hand swelling
hearing loss
HMGcoA reductase inhibitors
homocysteine, serum
hydrocephalus
hypercalcemia
hypertension
hypertensive crisis
hypertrophic intracranial pachymeningitis
immunosuppressive agents
indapamide
infliximab
insular cortex
interstitial pulmonary fibrosis
iritis
lymphadenopathy, hilar
malformation, CNS, congenital
malignant hypertension
meningeal enhancement
meningitis, aseptic
meningitis, basilar
meningitis, chronic
meningitis, noninfectious
meningitis, recurrent
meningomyelitis
microcephaly
microemboli
monoclonal antibodies
mononeuropathy
mononeuropathy multiplex
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, mismatch between perfusion/diffusion
myelitis, longitudinal
myelopathy
myopathy
neurologic consultation
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neuropathy
NIH stroke scale
optic neuropathy
perindopril
platelet inhibiting drugs
pleocytosis of cerebrospinal fluid
prevention of neurologic disorders
prognosis
PROGRESS trial
radiation therapy, CNS treatment and complications with
ramipril
renal biopsy
renal failure
renal failure, acute
review article
risk factors
risk factors, modification
sarcoidosis
sarcoidosis, CNS
sclerodactyly
scleroderma
seizure
serologic testing
serologic testing, false negative
skin, lesions in neurologic disorders
spina bifida
spinal cord, lesion of
statin therapy
stent, carotid artery
steroid therapy, CNS treatment and complications with
telmisartan
tissue plasminogen activator, intravenous
transient ischemic attack
transient ischemic attack, evaluation
transient ischemic attack, treatment of
treatment of neurologic disorder
tumor necrosis factor inhibitor
uveitis
visual loss
vitamin supplementation
workup
Showing articles 400 to 450 of 1276 << Previous Next >>

Statin Therapy should be Discontinued in Patients with Intracerebral Hemorrhage
Stroke 44:2058-2059,2062, Goldstein, L., 2013

Sarcoidosis Presenting as Longitudinally Extensive Myelitis
Neurol 81:e61, Goenka, N. & Venna N., 2013

Aggressive Medical Therapy Alone is Not Adequate in Certain Patients with Severe Symptomatic Carotid Stenosis
Stroke 44:2955-2956, Brown, M.M., 2013

Aggressive Medical Therapy Alone is Adequate in Certain Patients with Severe Symptomatic Carotid Stenosis
Stroke 44:2957-2958, Chaturvedi, S.,et al, 2013

Reduction in Early Stroke Risk in Carotid Stenosis with Transient Ischemic Attack Associated with Statin Treatment
Stroke 44:2814-2820, Merwick, A.,et al, 2013

Adult Attention Deficit - Hyperactivity Disorder
NEJM 369:1935-1944, Volkow, N.D. & Swanson, J.M., 2013

Faxtor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 44:e165-e167, Bruins, K.M.H., & Berge, E., 2013

Edoxaban Versus Warfarin in Patients with Atrial Fibrillation
NEJM 369:2093-2104, Giugliano, R.P.,et al, 2013

Neurological Immune-Related Adverse Events of Ipilimumab
Pract Neurol 13:278-280, Bot, I.,et al, 2013

Clinical Findings and Diagnosis in Human Granulocytic Anaplasmosis: A Case Series from Massachusetts
Mayo Clin Proc 87:233-239, Weil, A.A.,et al, 2012

Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas are Associated with Improved Survival Compared with Matched Controls
AJNR 33:1763-1770, Mong, S.,et al, 2012

Herpes Encephalitis During Natalizumab Tretament in Multiple Sclerosis
Mult Scler J 18:909-911, Kwiatkowski, A.,et al, 2012

Fatal Varicella-Zoster Virus Vasculopathy Associated with Adalimumab Therapy
Arch Neurol 69:1193-1196, Baek, W.,et al, 2012

Management of Anticoagulation Before and After Elective Surgery
www.uptodate.com Dec. 2012, Lip, G. & Douketis, J., 2012

Selective Serotonin Reuptake Inhibitors May be Helpful in Most Patients with Stroke
Stroke 43:3150-3151,3154, Chollet, F., 2012

Should Every Patient with Stroke be on Selective Serotonin Reuptake Inhibitors?
Stroke 43:3152-3153,3154, Marshall, R.S., 2012

Dropped Head Syndrome: Report of Three Cases During Treatment with a Mek Inhibitor
Neurol 79:1929-1932, Chen, X.,et al, 2012

Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012

PML-IRIS in a patient treated with Brentuximab
Neurol 79:2075-2077, Geldern, G.,et al, 2012

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomized controlled trial
Lancet 380:1749-1758, Lopes, R.,et al, 2012

Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation
Stroke 43:3442-3453, Furie, K.,et al, 2012

Bleeding During Treatment with Aspirin Versus Apixaban in Patients with Atrial Fibrillation Unsuitable for Warfarin
Stroke 43:3291-3297, Flaker, G.,et al, 2012

Nonvitamin K-Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack
Stroke 43:3298-3304, Ntaios, G.,et al, 2012

Myasthenia Gravis
BMJ 345:e8497, Spillane, J.,et al, 2012

Statin Use During Ischemic Stroke Hospitalization is Strongly Associated with Improved Poststroke Survival
Stroke 43:147-154, Flint, A.C.,et al, 2012

Using Dabigatran in Patients with Stroke A Practical Guide for Clinicians
Stroke 43:271-279, Alberts, M.J.,et al, 2012

Long-lasting Treatment Effect of Rituximab in MuSK Myasthenia
Neurol 78:189-193, Diaz-Manera,J.,et al, 2012

Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum
JNNP 83:124-137, Charidimou,A.,et al, 2012

Statins and Intracerebral Hemorrhage
Arch Neurol 69:39-45,13, Hackam,D.G,et al, 2012

Evidence-based Guideline: Antiepileptic Drug Selection for People with HIV/AIDS
Neurol 78:139-145, Birbeck,G.L.,et al, 2012

New Antithrombotic Drugs for Atrial Fibrillation: Caution is Needed
Lancet 379:e24, Bell,S.,et al, 2012

Anticoagulant Loses its Lustre
Lancet 379:301, Mullar,A., 2012

Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012

Fatal PML Associated with Efalizumab Therapy
Neurol 78:458-467, Schwab,N.,et al, 2012

The Argatroban and Tissue-Type Plasminogen Activator Stroke Study
Stroke 43:770-775,623, Barreto,A.D.,et al, 2012

Cost-Effectiveness of Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Stroke 43:881-883, Kamel,H.,et al, 2012

Critique of Apixaban Versus Warfarin in Patients with Atrial Fibrillation
Stroke 43:922-923, Nedeltchev,K, 2012

Clinicopathologic Conference,Necrotizing Noninflammatory Myopathy Consistent with Exposure to Statins
NEJM 36:944-954, Case 7-2012, 2012

Donepezil and Memantine for Moderate-to Severe Alzheimers Disease
NEJM 366:893-903,957, Howard,R.,et al, 2012

A Randomized, Double-Blind, Placebo-Controlled Trial of Antidepressants in Parkinson Disease
Neurol 78:1229-1236, Richard,I.H.,et al, 2012

Update on the Pathophysiology and Management of Idiopathic Intracranial Hypertension
JNNP 83:488-494, Biousse,V.,et al, 2012

Progress for Stroke Prevention with Atrial Fibrillation
Stroke 43:1179-1185, Katsnelson,M.,et al, 2012

Sildenafil-Induced Cervical Spinal Cord Infarction
AJNR 33:e32-e33, Walden,J.E. & Castillo,M., 2012

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
NEJM 366:1000-1009, Comi,G.,et al, 2012

Clinicalpathologic Conference, Vitamin B12 Deficiency due to Pernicious Anemia
NEJM 366:1626-1633, Case 13-2012, 2012

Treatment of Behcets Disease
UpToDate, Jan, Smith, E.L. & Yazici, Y., 2012

Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack
NEJM 366:1914-1922;, Davis, S.M. & Donnan, G.A., 2012

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012

Intracranial Optic Nerve Enlargement in Infantile Krabbe Disease
Neurol 78: e126, Shah, S.,et al, 2012

Intracraial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation with Warfarin or Dabigatran
Stroke 43:1511-1517, Hart, R.G.,et al, 2012



Showing articles 400 to 450 of 1276 << Previous Next >>